2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
26
Genitourinary
12
Other hematologic neoplasm
6
Breast
6
Gynecologic
5
Thoracic
2
Plasma cell
2
Lymphoid
2
Head & Neck
2
Other
1
NET
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Multiple Myeloma
3577
Neoplasms, Plasma Cell
696
Lymphoma
531
Lymphoma, Non-Hodgkin
480
Leukemia, Lymphocytic, Chronic, B-Cell
409
Hodgkin Disease
405
Recurrence
404
Precursor Cell Lymphoblastic Leukemia-Lymphoma
375
Leukemia
373
Leukemia, Myeloid, Acute
363
Myelodysplastic Syndromes
331
Lymphoma, Large B-Cell, Diffuse
290
Lymphoma, Mantle-Cell
288
Lymphoma, Follicular
284
Lymphoma, B-Cell, Marginal Zone
256
Burkitt Lymphoma
249
Immunoglobulin Light-chain Amyloidosis
227
Myeloproliferative Disorders
226
Lymphoma, Large-Cell, Immunoblastic
223
Neoplasms
214
Hematologic Neoplasms
200
Primary Myelofibrosis
186
Leukemia, Myeloid, Chronic-Phase
182
Leukemia, Myeloid, Accelerated Phase
173
Lymphoma, T-Cell, Cutaneous
170
Waldenstrom Macroglobulinemia
164
Blast Crisis
162
Leukemia, Myelomonocytic, Chronic
158
Mycosis Fungoides
147
Sezary Syndrome
146
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Frailty
×
Plasma cell
×
Clear all
NCT06099912
2026-02-12
DynaFiT
The First Hospital of Jilin University
Recruiting
131 enrolled
NCT06247189
2025-12-22
Onco-ICOPE
University Hospital, Toulouse
Phase NA
Recruiting
30 enrolled